National Vaccine
Information Center

Your Health. Your Family. Your Choice.

MedAlerts Home
Search Results

From the 10/15/2021 release of VAERS data:

Found 183 cases where Location is U.S., Territories, or Unknown and Vaccine is COVID19 and Manufacturer is JANSSEN and Symptom is Guillain-Barre syndrome



Case Details

This is page 10 out of 19

Result pages: prev   1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19   next


VAERS ID: 1470607 (history)  
Form: Version 2.0  
Age: 53.0  
Sex: Female  
Location: Louisiana  
Vaccinated:2021-03-05
Onset:2021-06-07
   Days after vaccination:94
Submitted: 0000-00-00
Entered: 2021-07-14
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (JANSSEN)) / JANSSEN 1805018 / 1 - / -

Administered by: Other       Purchased by: ?
Symptoms: Guillain-Barre syndrome
SMQs:, Peripheral neuropathy (narrow), Guillain-Barre syndrome (narrow), Demyelination (narrow), Immune-mediated/autoimmune disorders (narrow)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications: amlodipine besylate 10 mg vitamin d2 pravastatin 80 mg zolpidem 10 mg asprin 81 mg Tylenol
Current Illness:
Preexisting Conditions: high blood pressure high colterol fibromyalgia ptsd ibs
Allergies:
Diagnostic Lab Data:
CDC Split Type:

Write-up: gbs


VAERS ID: 1470657 (history)  
Form: Version 2.0  
Age: 55.0  
Sex: Male  
Location: Puerto Rico  
Vaccinated:2021-04-09
Onset:2021-06-10
   Days after vaccination:62
Submitted: 0000-00-00
Entered: 2021-07-14
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (JANSSEN)) / JANSSEN 203A21A / 1 LA / IM

Administered by: Pharmacy       Purchased by: ?
Symptoms: Anal incontinence, Asthenia, Cardiopulmonary bypass, Diarrhoea, Full blood count, Guillain-Barre syndrome, Headache, Immunoglobulin therapy, Influenza virus test, Intensive care, Lumbar puncture, Mycoplasma test, Nasal congestion, Pain in extremity, Paralysis, Pyrexia, SARS-CoV-2 test, Urinary incontinence
SMQs:, Peripheral neuropathy (narrow), Neuroleptic malignant syndrome (broad), Anticholinergic syndrome (broad), Pseudomembranous colitis (broad), Guillain-Barre syndrome (narrow), Noninfectious encephalitis (broad), Gastrointestinal nonspecific symptoms and therapeutic procedures (narrow), Demyelination (narrow), Conditions associated with central nervous system haemorrhages and cerebrovascular accidents (broad), Noninfectious diarrhoea (narrow), Tendinopathies and ligament disorders (broad), Drug reaction with eosinophilia and systemic symptoms syndrome (broad), Immune-mediated/autoimmune disorders (narrow), COVID-19 (broad)

Life Threatening? Yes
Birth Defect? No
Died? No
Permanent Disability? Yes
Recovered? No
Office Visit? Yes
ER Visit? No
ER or Doctor Visit? Yes
Hospitalized? Yes, 27 days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications: Irbesartan-Hydrochlorothiazide 150-12.5 mg
Current Illness: Hypertension
Preexisting Conditions: Hypertension
Allergies: No Known Allergies
Diagnostic Lab Data: Covid-19 Test, Influenza Test, Mycoplasma Test, Lumbar Punction (6/20/2021), CBC
CDC Split Type:

Write-up: Adverse Events: Headache, Fever, Diarrhea, Nasal Congestion, Leg Pain, Weakness, Paralysis Dx. Guillain Barre Treatment: Immunoglobulin, Sodium Chloride 0.9%, Respiratory Bypass, Oxygen Outcomes: Patient actually in Intensive Care Unit at Hospital receiving treatment. Continue with oxygen by nasal cannula, whole body paralysis with urinary and feccal incontinence (foley and diaper). Symptoms begin since June 10,2021. Admission to Hospital on June 17, 2021 to present.


VAERS ID: 1470745 (history)  
Form: Version 2.0  
Age: 33.0  
Sex: Female  
Location: Arizona  
Vaccinated:2021-03-31
Onset:2021-06-24
   Days after vaccination:85
Submitted: 0000-00-00
Entered: 2021-07-14
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (JANSSEN)) / JANSSEN 1805020 / 1 - / IM

Administered by: Private       Purchased by: ?
Symptoms: Blood gases normal, Blood lactic acid normal, Blood magnesium normal, Computerised tomogram head normal, Dyspnoea, Endotracheal intubation, Full blood count normal, Guillain-Barre syndrome, Influenza virus test negative, Intensive care, Metabolic function test, Mobility decreased, Muscular weakness, SARS-CoV-2 test negative, Urine analysis normal
SMQs:, Rhabdomyolysis/myopathy (broad), Anaphylactic reaction (broad), Angioedema (broad), Peripheral neuropathy (narrow), Parkinson-like events (broad), Acute central respiratory depression (broad), Pulmonary hypertension (broad), Guillain-Barre syndrome (narrow), Noninfectious encephalopathy/delirium (broad), Cardiomyopathy (broad), Demyelination (narrow), Respiratory failure (broad), Tendinopathies and ligament disorders (broad), Immune-mediated/autoimmune disorders (narrow), COVID-19 (broad)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? Yes
Hospitalized? Yes, ? days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications: Cetirizine Albuterol Iron supplement (oral) Vit C
Current Illness: Nio
Preexisting Conditions: Iron deficiency anemia GE Reflux 1997: rheumatic heart disease-monthly bicillin Severe obesity, BMI=54
Allergies: Vancomycin
Diagnostic Lab Data: see above
CDC Split Type:

Write-up: Guillain Barre suspected Area Hospital Admitted Admit date: 06/27/2021 Admitting Diagnosis: Worsening generalized weakness-secondary to possible Guillian Barr? Syndrome History of Present Illness: This is a 34-year-old female patient that presented at sells emergency department with a medical history of recent upper respiratory infection, obesity, asthma who stated she is short of breath. She has generalized muscular weakness x3 days and per mother''s report, the patient was unable to get out of bed and required max assist. The patient had a CT of the head, influenza swab, COVID-19 swab, CBC, CMP, magnesium level, lactic acid, venous blood gas and urinalysis. All imaging and diagnostic lab work were negative and within normal limits. Due to worsening weakness, the ED provider in hospital intubated the patient for transfer to Hospital ICU for further evaluation and treatment.


VAERS ID: 1471835 (history)  
Form: Version 2.0  
Age: 57.0  
Sex: Male  
Location: California  
Vaccinated:2021-06-13
Onset:2021-06-27
   Days after vaccination:14
Submitted: 0000-00-00
Entered: 2021-07-15
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (JANSSEN)) / JANSSEN - / UNK - / -

Administered by: Private       Purchased by: ?
Symptoms: Acute respiratory failure, Aphonia, Asthenia, Choking, Dysphagia, Endotracheal intubation, Guillain-Barre syndrome, Hypoaesthesia, Plasmapheresis
SMQs:, Anaphylactic reaction (broad), Angioedema (broad), Peripheral neuropathy (narrow), Anticholinergic syndrome (broad), Shock-associated circulatory or cardiac conditions (excl torsade de pointes) (broad), Torsade de pointes, shock-associated conditions (broad), Hypovolaemic shock conditions (broad), Toxic-septic shock conditions (broad), Anaphylactic/anaphylactoid shock conditions (broad), Hypoglycaemic and neurogenic shock conditions (broad), Oropharyngeal conditions (excl neoplasms, infections and allergies) (narrow), Acute central respiratory depression (narrow), Guillain-Barre syndrome (narrow), Noninfectious encephalitis (broad), Noninfectious encephalopathy/delirium (broad), Noninfectious meningitis (broad), Gastrointestinal nonspecific symptoms and therapeutic procedures (broad), Demyelination (narrow), Hypersensitivity (broad), Respiratory failure (narrow), Immune-mediated/autoimmune disorders (narrow), Sexual dysfunction (broad)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? Yes, 6 days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions: BPH, diverticulitis
Allergies: penicillin
Diagnostic Lab Data:
CDC Split Type:

Write-up: Patient admitted with worsening numbness and weakness 2 weeks after vaccination; Neurology consulted and patient diagnosed with acute inflammatory demyelinating polyradiculoneuropathic form of Guillain-Barr? syndrome and underwent plasmapharesis. Patient continued with progressive weakness difficulty with swallowing and choking on food as well as progressive loss of voice. Patient subsequently developed acute respiratory failure, transferred to critical care and was intubated.


VAERS ID: 1475203 (history)  
Form: Version 2.0  
Age: 68.0  
Sex: Female  
Location: Washington  
Vaccinated:2021-03-30
Onset:2021-04-12
   Days after vaccination:13
Submitted: 0000-00-00
Entered: 2021-07-15
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (JANSSEN)) / JANSSEN 041A21A / 1 LA / IM

Administered by: Private       Purchased by: ?
Symptoms: Angiogram, Cardiac monitoring, Chest X-ray, Computerised tomogram abdomen, Computerised tomogram thorax, Differential white blood cell count, Electrocardiogram, Full blood count, Guillain-Barre syndrome, Laboratory test, Metabolic function test, Troponin, Troponin I
SMQs:, Peripheral neuropathy (narrow), Guillain-Barre syndrome (narrow), Demyelination (narrow), Immune-mediated/autoimmune disorders (narrow)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? Yes
Hospitalized? No
Previous Vaccinations:
Other Medications: unknown-received information via essence reporT
Current Illness: unknown-received information via essence report
Preexisting Conditions: unknown-received information via essence report
Allergies: unknown-received information via essence report
Diagnostic Lab Data: LAB1748 CBC WITH AUTO DIFFERENTIAL;LAB17 COMPREHENSIVE METABOLIC PANEL;RIS1259 XR CHEST 1V PORTABLE;ECG1 EKG 12-LEAD;IVT3 INSERT PERIPHERAL IV;NUR586 CONTINUOUS PULSE OXIMETRY;NUR342 ED NASAL CANNULA OXYGEN;NUR7021 CARDIAC MONITORING;LAB6953 TROPONIN 0; 1; 3 HR HIGH SENSITIVITY;LAB6386 *CBC WITH AUTO DIFFERENTIAL; LAB GENERATED ORDER;LAB6896 *TROPONIN I HS 0 HR (LAB GENERATED ORDER);LAB6956 *TROPONIN I HS 1 HOUR (LAB GENERATED ORDER);LAB1778 LIGHT GREEN TOP;RIS3218 CTA CHEST ABDOMEN PELVIS;LAB6957 *TROPONIN I HS 3 HOUR (LAB GENERATED ORDER)
CDC Split Type:

Write-up: Admitted for HTN, diagnosed with GBS and discharged on 13 April.


VAERS ID: 1478029 (history)  
Form: Version 2.0  
Age: 59.0  
Sex: Female  
Location: New Jersey  
Vaccinated:2021-03-17
Onset:2021-04-06
   Days after vaccination:20
Submitted: 0000-00-00
Entered: 2021-07-16
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (JANSSEN)) / JANSSEN - / UNK - / -

Administered by: Private       Purchased by: ?
Symptoms: CSF protein increased, Guillain-Barre syndrome, Lumbar puncture, Red blood cell count increased, White blood cell count normal
SMQs:, Peripheral neuropathy (narrow), Guillain-Barre syndrome (narrow), Demyelination (narrow), Immune-mediated/autoimmune disorders (narrow)

Life Threatening? Yes
Birth Defect? No
Died? No
Permanent Disability? Yes
Recovered? Yes
Office Visit? Yes
ER Visit? No
ER or Doctor Visit? Yes
Hospitalized? Yes, 19 days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications: sisingulair ramipril phenobarbital lipitor coumadin aspirin
Current Illness: N/A
Preexisting Conditions: cervical spine cord compression
Allergies: carbamazepine dilantin
Diagnostic Lab Data: Lumbar puncture - 2 WBC, <1000 RBC, protein 1960
CDC Split Type:

Write-up: Patient was hospitalized for Guillain Barre Syndrome


VAERS ID: 1478150 (history)  
Form: Version 2.0  
Age: 49.0  
Sex: Male  
Location: Texas  
Vaccinated:2021-04-12
Onset:2021-06-21
   Days after vaccination:70
Submitted: 0000-00-00
Entered: 2021-07-16
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (JANSSEN)) / JANSSEN - / UNK - / IM

Administered by: Private       Purchased by: ?
Symptoms: Guillain-Barre syndrome, Lumbar puncture
SMQs:, Peripheral neuropathy (narrow), Guillain-Barre syndrome (narrow), Demyelination (narrow), Immune-mediated/autoimmune disorders (narrow)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? Yes
ER Visit? No
ER or Doctor Visit? Yes
Hospitalized? Yes, 7 days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications: gemfibrozil metoprolol metformin losartan fiorcet asa coQ10 magnesium zyrtec
Current Illness:
Preexisting Conditions: hypertension hyperglycemia hyperlipidemia migrains hx of melanoma
Allergies: no known allergies
Diagnostic Lab Data: spinal tap proved dx
CDC Split Type:

Write-up: pt was diagnosed with Guillian Barre syndrome 06/22/2021


VAERS ID: 1478296 (history)  
Form: Version 2.0  
Age: 62.0  
Sex: Male  
Location: Texas  
Vaccinated:2021-03-12
Onset:2021-03-24
   Days after vaccination:12
Submitted: 0000-00-00
Entered: 2021-07-16
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (JANSSEN)) / JANSSEN - / 1 RA / IM

Administered by: Other       Purchased by: ?
Symptoms: Abdominal discomfort, Abdominal distension, Abdominal pain, Angiogram, CSF protein increased, Discomfort, Dyskinesia, Eyelid function disorder, Facial paralysis, Facial paresis, Flatulence, Gastrointestinal motility disorder, Guillain-Barre syndrome, Immunoglobulin therapy, Lumbar puncture abnormal, Magnetic resonance imaging head normal, Muscular weakness, Pain, Pain in extremity, Scan with contrast
SMQs:, Rhabdomyolysis/myopathy (broad), Acute pancreatitis (broad), Peripheral neuropathy (narrow), Neuroleptic malignant syndrome (broad), Retroperitoneal fibrosis (broad), Dyskinesia (narrow), Gastrointestinal perforation, ulcer, haemorrhage, obstruction non-specific findings/procedures (broad), Gastrointestinal obstruction (narrow), Guillain-Barre syndrome (narrow), Noninfectious encephalitis (broad), Noninfectious encephalopathy/delirium (broad), Noninfectious meningitis (broad), Gastrointestinal nonspecific dysfunction (broad), Gastrointestinal nonspecific symptoms and therapeutic procedures (narrow), Demyelination (narrow), Hearing impairment (broad), Periorbital and eyelid disorders (narrow), Ocular motility disorders (narrow), Noninfectious diarrhoea (broad), Tendinopathies and ligament disorders (broad), Immune-mediated/autoimmune disorders (narrow)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? Yes
Recovered? No
Office Visit? Yes
ER Visit? No
ER or Doctor Visit? Yes
Hospitalized? Yes, 14 days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications: Metformin, Glipizide, Atorvastatin, Lisinopril
Current Illness: none
Preexisting Conditions: High blood pressure, High Cholesterol, Type II diabetes
Allergies: none
Diagnostic Lab Data: MRI, MRA and MRI with Contrast - Test date were approx. 5-1-2021 to 5-9-2021 Spinal Tap - Test date were approx. 5-1-2021 to 5-9-2021
CDC Split Type:

Write-up: On March 24 I began experiencing severe pain in my right arm. The er thought it might have been a pinched nerve or something along those line. March 28, noticed a lack of muscle control on the right side of my lips while drinking from a straw. This time I was admitted as a possible stroke. Two different MRI sessions revealed no stroke. They performed a lumbar puncture and discovered that I had extremely high protein levels. After having been admitted, for the next couple of days my face slowly lost the ability to close my eyes fully and a complete lack of control of my lips (total paralysis on my face). I also began to experience bouts of stabbing pain throughout my body and weakness in my limbs. After the after th


VAERS ID: 1481163 (history)  
Form: Version 2.0  
Age: 55.0  
Sex: Male  
Location: Utah  
Vaccinated:0000-00-00
Onset:2021-03-18
Submitted: 0000-00-00
Entered: 2021-07-17
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (JANSSEN)) / JANSSEN 1805025 / UNK - / -

Administered by: Other       Purchased by: ?
Symptoms: Bell's palsy, Blood test, Chills, Guillain-Barre syndrome, Headache, Laboratory test, Magnetic resonance imaging, Nerve conduction studies, Pyrexia
SMQs:, Peripheral neuropathy (narrow), Neuroleptic malignant syndrome (broad), Anticholinergic syndrome (broad), Guillain-Barre syndrome (narrow), Demyelination (narrow), Hearing impairment (broad), Drug reaction with eosinophilia and systemic symptoms syndrome (broad), Immune-mediated/autoimmune disorders (narrow)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? Yes
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness: Drug allergy (Erythromycin, sulfa)
Preexisting Conditions:
Allergies:
Diagnostic Lab Data: Test Date: 20210527; Test Name: Laboratory test; Result Unstructured Data: Guillen Barre Syndrome; Test Name: Blood test; Result Unstructured Data: not reported; Test Name: Nerve conduction studies; Result Unstructured Data: GBS and chronic inflammatory; Test Name: MRI; Result Unstructured Data: not reported
CDC Split Type: USJNJFOC20210726161

Write-up: GUILLEN BARRE SYNDROME; BELLS PALSY/FACE DROOPING; CHILLS; HEADACHES/EXCRUCIATING HEADACHES; FEVER; This spontaneous report was received from a consumer and concerned a 55 year old male. The patient''s height and weight were not reported. The patient''s concurrent conditions included drug allergy. Other relevant history included general good health and a marathon runner. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, intramuscular, batch number: 1805025, expiry: 09-JUL-2021) dose was not reported, administered on 17-MAR-2021 to left arm for prophylactic vaccination. No concomitant medications were reported. On 18-MAR-2021, the patient experienced fever, chills and headaches. On 14-APR-2021, patient thought he had eaten something that had burned his lip. On 18-APR-2021, the patient experienced bells palsy/face drooping. His "lip going numb" then "face started drooping". He went to the emergency room. The doctors proceeded with an MRI and "all sorts of bloodwork." Patient also had "leg started to have twitching" and then started to have excruciating headaches ", "back started hurting on around the 22nd or 23rd of April" and "his legs and feet were numb" and "just couldn''t get his utensils", "body weakness and headaches." He went to a neurologist and had a nerve conducting study and "it looked like it was GBS and chronic inflammatory." On 27-MAY-2021, Guillen Barre syndrome was diagnosed. Treatment medications included: ibuprofen, gabapentin, sodium chloride, paracetamol, naproxen, and plasma infusions to help with GBS. At the neurologist, the patient had 5 treatments of plasma. He was having reactions with the infusion including "light headedness or headaches." He was given saline and the doctors told him to "stay hydrated and also was suggested acetaminophen and ibuprofen." He was also having "extreme weakness" with the plasma therapy. The neurologist was looking into the diagnosis and determined as it "is a reaction to the vaccine". The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of Guillen Barre syndrome was not reported. The patient recovered from Bells Palsy/face drooping on 23-APR-2021, and fever and chills on an unspecified date, and had not recovered from headaches/excruciating headaches. This report was serious (Other Medically Important Condition). This case, from the same reporter is linked to 20210726629.; Sender''s Comments: V0: This spontaneous report received from a consumer concerns a 55 year old male, who was noted to have bell''s palsy and diagnosed with Guillain-Barre syndrome (GBS) 32 and 71 days, respectively, after receiving the Janssen Covid-19 vaccine. Patient''s height and weight were not reported. The patient''s past medical/surgical history, concurrent conditions and concomitant medications were not reported. Information on smoking history, illicit drug use and alcohol abuse were not provided. Patient has drug allergy, unspecified. Patient had fever, chills and headache one day after receiving the vaccine. Thirty-two (32) days post vaccine, the patient''s face started to droop and was noted to have bells palsy. He sought consult at the emergency room and was worked up on. No results provided. Patient started experiencing twitching of his legs, excruciating headaches and back pains. Later, his legs and feet started to get numb, described as not being able to get his utensils. His body started to get weak and he still was experiencing headaches. He went to a neurologist and had a nerve conducting study. Seventy-one (71) days after receiving the vaccine, patient was diagnosed with Guillain-Barre Syndrome (GBS). Treatment medications included: ibuprofen, gabapentin, sodium chloride, paracetamol, naproxen, and plasma infusions. Information regarding other potential etiologies was insufficient, and the occurrence of Bells Palsy and GBS could represent background incidence of such events in the general population. Considering the temporal relationship, the event is assessed to have an indeterminate relationship with vaccination.


VAERS ID: 1481231 (history)  
Form: Version 2.0  
Age:   
Sex: Male  
Location: Indiana  
Vaccinated:0000-00-00
Onset:0000-00-00
Submitted: 0000-00-00
Entered: 2021-07-17
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (JANSSEN)) / JANSSEN UNKNOWN / UNK - / -

Administered by: Other       Purchased by: ?
Symptoms: Guillain-Barre syndrome
SMQs:, Peripheral neuropathy (narrow), Guillain-Barre syndrome (narrow), Demyelination (narrow), Immune-mediated/autoimmune disorders (narrow)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions:
Allergies:
Diagnostic Lab Data:
CDC Split Type: USJNJFOC20210728662

Write-up: GUILLAIN-BARRE SYNDROME; This spontaneous report was received from a consumer (bother-in-law of the patient) and concerned a male patient in his 60''s of unspecified race and ethnicity. The patient''s height and weight were not reported. The patient''s past medical history was not reported. The patient received COVID-19 vaccine Ad26.CoV2.S (suspension for injection, route of administration unknown, batch number unknown), dose, vaccination site, and vaccination date not reported, once in total, for prophylactic vaccination. Batch number was not reported. Company will conduct follow up to obtain batch number. No concomitant medications were reported. On an unspecified date, the patient experienced Guillain-Barre syndrome. The action taken with COVID-19 vaccine Ad26.CoV2.S was not applicable. The outcome of Guillain-Barre syndrome was not reported. This report was serious (other medically important condition).; Sender''s Comments: V0: This spontaneous report received from the brother-in-law of the patient concerns a male in his 7th decade of life who experienced Guillain-Barre Syndrome an unspecified period of time after receiving the Janssen Covid-19 vaccine. Medical history, concomitant medications, clinical symptoms, diagnostic testing, corrective treatment, and outcome were not reported. The relationship of the event to vaccination is considered unclassifiable due to insufficient information. Additional information will be requested.


Result pages: prev   1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19   next

New Search

Link To This Search Result:

https://medalerts.org/vaersdb/findfield.php?EVENTS=ON&PAGENO=10&SYMPTOMS=Guillain-Barre_syndrome_%2810018767%29&VAX=COVID19&VAXMAN=JANSSEN&STATE=NOTFR

Government Disclaimer on use of this data


Copyright © 2021 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166